Sept 8 (Reuters) - SENSORION SA ALSEN.PA :
- SENSORION AND COCHLEAR TO BEGIN FIRST CLINICAL TRIAL OF SENS-401 FOR HEARING PRESERVATION IN COMBINATION WITH COCHLEAR IMPLANTATION
- STUDY WILL AIM TO MEASURE PERILYMPH PK OF SENS401 AND TO EXPLORE THERAPEUTIC EFFECT OF SENS-401 ON EARLY HEARING OUTCOMES UPON COCHLEAR IMPLANTATION
- TRIAL WILL BE FULLY FUNDED UNDER EXISTING AGREEMENT BETWEEN COCHLEAR AND SENSORION
News: COH Sensorion, Cochlear To Begin First Clinical Trial Of SENS-401
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$319.42 |
Change
2.420(0.76%) |
Mkt cap ! $20.88B | |||
| Open | High | Low | Value | Volume |
| $317.80 | $319.56 | $315.50 | $38.61M | 121.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 72 | $318.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $319.50 | 27 | 1 |
View Market Depth
| Last trade - 16.10pm 29/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |